HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk

Vanderbilt University Medical Center (VUMC)

Vanderbilt University Medical Center (VUMC) is committed to excellence in patient care, leadership in research, and preeminence in medical education. Our culture thrives on challenges and champions innovation, while striving to make healthcare personal.

Connect with us:

Latest from Vanderbilt University Medical Center (VUMC)

Trofinetide as an Option for Rett Syndrome Treatment

September 19, 2022

Study investigator Jeffrey L. Neul, MD, PhD, offered his perspective on the current understanding of trofinetide (Acadia Pharmaceuticals) and its potential in Rett syndrome if approved by the FDA in the coming months.

FDA Accepts Application for Trofinetide in Rett Syndrome

September 12, 2022

The treatment, previously known as NNZ-2566, is supported by data from the LAVENDER study. With no plans to hold an advisory meeting, the agency set a PDUFA date of March 12, 2023, for the Acadia Pharmaceuticals product.